RESONETICS acquired by THE CARLYLE GROUP & GTCR
Context
The strategic investment in Resonetics by Carlyle signifies a major territorial and technical advancement for the organization, building upon the momentum of eight successful add-on acquisitions. The strategic rationale for this transaction centers on a "platform-acceleration" maneuver, merging the target's industry-leading technical operational depth in micro-manufacturing with the new sponsor’s extensive global network and expertise in healthcare digitalization. This alignment provides the organization with the scientific talent and technological hardware required to address the increasing clinical demand for miniaturized, minimally invasive interventional components.
RESONETICS, which reported an EBITDA margin of [members only] in 2021, is valued in this transaction at an EV/EBITDA multiple of [members only], to compare with the average currently observed in the Healthcare & Pharma sector (14.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
Resonetics is a Medical Device Contract Manufacturing company based in the USA, specializing in the high-precision micro-manufacturing of components for interventional medical devices. The organization operates as a primary innovation partner for global medtech OEMs, focusing on laser processing, nitinol shaping, and centerless grinding for minimally invasive applications. Rather than focusing on commodity hardware, the firm thrives on a philosophy of technical operational depth, providing sophisticated engineering solutions for miniaturized devices in neurovascular and cardiovascular therapies. Its utility resides in its ability to support customers across the entire product lifecycle, from initial design and development in specialized labs to high-volume manufacturing.
Ent. Value
$1–10bn
Equity Value
[members only]
Multiples
EV / Revenue
[members only]
EV / EBITDA
[members only]
EV / EBIT
[members only]
Historical Financials (USD)
Other operations with RESONETICS
Other operations with RESONETICS
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 03/2026 | RESONETICS | RESOLUTION MEDICAL | UNITED STATES | Medical Devices |
| 10/2023 | RESONETICS | NITINOL BUSINESS | UNITED STATES | Medical Devices |
Similar deals in Life Sciences
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 01/2022 | PERMIRA | BIO PRODUCTS LABORATORY (BPL) | UNITED KINGDOM | CDMO |
| 01/2022 | ANJAC BEAUTY & HEALTH | APOLLO HEALTHCARE CORP. | CANADA | CDMO |
| 12/2021 | WINNCARE | PHARMAOUEST INDUSTRIES | FRANCE | Medical Devices |
| 12/2021 | PLANMECA GROUP | KAVO DENTAL | GERMANY | Medical Devices |
| 12/2021 | INTEGER | OSCOR | UNITED STATES | Implants & Prosthetics |
| 11/2021 | COLOPLAST | ATOS MEDICAL | SWEDEN | Medical Consumables |
| 09/2021 | PERRIGO COMPANY | HRA PHARMA | FRANCE | Generics / Labs |
| 07/2021 | PARTNERS GROUP | PHARMATHEN | GREECE | CDMO |
| 07/2021 | ORKLA | NUTRAQ | Norway | Nutrition & Dietary Supplements |
| 07/2021 | MONTAGU PRIVATE EQUITY | INTECH MEDICAL | FRANCE | Implants & Prosthetics |
Other operations with THE CARLYLE GROUP / GTCR
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 10/2026 | THE CARLYLE GROUP | NIDEC COMPONENTS | JAPAN | Sensors & Optics |
| 09/2026 | THE CARLYLE GROUP / CVC | BauWatch | NETHERLANDS | Security & Guarding |
| 07/2026 | THE CARLYLE GROUP | Secturion Systems | UNITED STATES | Electronics |
| 09/2025 | THE CARLYLE GROUP / BPIFRANCE | CIRIL GROUP | FRANCE | Industry-Specific Software |
| 07/2025 | THE CARLYLE GROUP | ADASTRA GROUP | CANADA | Engineering & Consulting |
| 10/2023 | THE CARLYLE GROUP | LOCABOX | FRANCE | Warehousing / 3PL |
| 05/2023 | THE CARLYLE GROUP | MEOPTA-OPTIKA | CZECH REPUBLIC | Sensors & Optics |
| 01/2023 | THE CARLYLE GROUP | GROUPE LACOUR | FRANCE | Automotive |
| 12/2022 | THE CARLYLE GROUP | TESCAN GROUP | CZECH REPUBLIC | Instrumentation & Measurement |
| 05/2022 | THE CARLYLE GROUP | ManTech International Corporation | UNITED STATES | Cybersecurity Services |
REFERENCES
Valuation range: EV $1–10bn
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of RESONETICS by THE CARLYLE GROUP / GTCR are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Press release: view release
Target: resonetics
Acquirer: the carlyle group / gtcr